Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

4.97USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
93,000
52-wk High
$20.17
52-wk Low
$4.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.634
Jun '18 0.00 -0.595
Mar '18 0.00 -0.460
FY 2017 Dec '17 0.00 -1.606
Sep '17 0.00 -0.564
Jun '17 0.00 -0.472
Mar '17 0.00 -0.419
FY 2016 Dec '16 0.00 -0.361
Sep '16 0.00 -0.415
Jun '16 0.00 -0.423
Mar '16 0.00 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.00 0.00 0.00 13.00
Quarter Ending Mar-19 3 2.03 2.70 1.30 16.90
Year Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 18.61 25.30 11.00 57.99
Earnings (per share)
Quarter Ending Dec-18 5 -0.52 -0.45 -0.60 -0.61
Quarter Ending Mar-19 4 -0.64 -0.43 -0.78 -0.66
Year Ending Dec-18 5 -2.20 -2.11 -2.30 -1.71
Year Ending Dec-19 5 -2.35 -2.03 -2.84 -1.76
LT Growth Rate (%) 1 -61.50 -61.50 -61.50 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.54 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) 49.92 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 24.74 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.50 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago -57.16 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 3.55 3.43 3.10
LT Debt to Equity (MRQ) 68.25 18.73 11.49
Total Debt to Equity (MRQ) 88.50 31.43 16.03
Interest Coverage (TTM) -32.37 -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -- -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -- -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -- -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,652,294 873,073,486
Net Income/Employee (TTM) -1,552,280 652,908 103,486,338
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) -- 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -- 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -- 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -98.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kala Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.02 -14.09 43 98
13 Week -- -- -- 94
26 Week -- -- -- 98
52 Week -- -- -- 68
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.24%
# of Holders: 107
Total Shares Held: 23,061,735
3 Mo. Net Change: 1,289,028
# New Positions: 23
# Closed Positions: 22
# Increased Positions: 50
# Reduced Positions: 46
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.